Jump to Navigation

Facebook Connect

User login

CLM-SAP 16: Hypertriglyceridemia - Diagnosis, Pathophysiology, Clinical Significance and Treatment

CLM-SAP 16 is an online self-assessment program that will objectively validate and enhance your clinical knowledge of hypertriglyceridemia. Hypertriglyceridemia is associated with an increased risk of cardiovascular events and acute pancreatitis. The reduction in elevated levels of non-HDL-C, a marker of increased concentrations of circulating triglyceride-rich lipoproteins, is associated with reduced atherosclerotic cardiovascular risk. Similarly, a reduction in markedly elevated serum triglyceride levels decreases the risk of pancreatitis. This program will provide strategies to integrate evidence-based medicine into daily practice in order to appropriately assess, manage, and treat patients with hypertriglyceridemia.

Get real time feedback after each question, including a detailed critique and bibliographic references for further reading and receive a PDF copy of the program upon claiming CME/CE credit. Complete via computer or from tablet app for iPad and Android devices*.

Available Program Formats

Online Version: Get real-time feedback after each question. Detailed critique of each item along with bibliographic references.

You are not currently logged in. If you are an NLA Member, you can save time by logging in before visiting this activity.

Click here to take this activity as a Non-Member

Tablet Versions: Convenient tablet apps for iPadĀ® and AndroidTM allow you to take the CLM-SAP with you, wherever there is an internet connection. Best of all, you can move seamlessly back and forth between our desktop web browser version and the tablet version.*

*NLA members only

Download from the App Store Download from the GooglePlay Store

Accreditation Information

You are not currently logged in. If you are an NLA Member, you can save time by logging in before visiting this activity.

Click here to take this activity as a Non-Member

Content Domain
This activity falls under the following content domain(s):

  • 3.1.5 Hypertriglyceridemias
  • 5.3.1 Hypertriglyceridemia
  • 8.5.3 Severe hypertriglyceridemia management

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Define diagnostic criteria for type 2 diabetes and the association of insulin resistance to the development of dyslipidemia and cardiovascular disease
  2. Define treatment goals for patients with hypertriglyceridemia based on the most currently available guidelines, integrating results of clinical trials into comprehensive management strategies
  3. Describe gender and ethnic differences in the clinical presentation of hypertriglyceridemia
  4. Describe normal triglyceride physiology and pathophysiology
  5. Describe pharmacologic and non-pharmacologic (diet and lifestyle modification) therapies used for the treatment of dyslipidemia and the management of hypertriglyceridemia
  6. Discuss the management of of hypertriglyceridemia in patients with HIV
  7. Discuss the potential benefits of gastric bypass surgery in patients who are obese with other co-morbid conditions
  8. Identify genetic and acquired disorders associated with hypertriglyceridemia
  9. Identify the relationship between serum triglyceride levels and risk for atherosclerotic cardiovascular disease
  10. Recognize the value of non-HDL-C in the diagnosis and treatment of triglyceride disorders



by Dr. Radut.